Antsvoris klinikiniai tyrimai Utah
22 tyrimai dėl Antsvoris ieško dalyvių vietose Utah.
Miestai Utah
Oficialus tyrimo tekstas (anglų kalba)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- AMR Clinical, Layton
Renkami dalyviai3 fazė
Amžius nuo 8 iki 18 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07253285Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- AMR Clinical, South Jordan
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07837973A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Velocity Clinical Research, Salt Lake City, West Jordan
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Ogden Clinic - Canyon View, Ogden
- Diabetes & Endocrine Treatment Specialists, Sandy City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Boeson Research, Provo
- Velocity Clinical Research - Salt Lake City, West Jordan
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, South Jordan
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07353931A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Salt Lake City
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Kalo Clinical Research, West Valley City
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Tanner Clinic, Layton
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Pleasant View
- Kailera Clinical Site, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Pantheon Clinical Research, Bountiful
- Alliance for Multispecialty Research Layton Research Center, Layton
- Chrysalis Clinical Research, LLC, St. George
Renkami dalyviai3 fazė
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684235Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284875A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- ICON Early Phase Services, LLC, Salt Lake City
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07654972A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Salt Lake City
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07784725Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Sandy City
- ACCOMPLISH-1 Research Site, St. George
Renkami dalyviai3 fazė
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361Circadian Intervention to Improve Cardiometabolic Health
- College of Health Research Complex--University of Utah, Salt Lake City
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 45 · Visoms lytims · Atnaujinta 2026-08-05 · NCT05943626Effect of Sleep Extension on Ceramides in People With Overweight and Obesity
- College of Health Research Complex--University of Utah, Salt Lake City
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 45 · Visoms lytims · Atnaujinta 2026-08-05 · NCT06180837Testing a Tailored Approach to Long-Term Weight Loss Success
- University of Utah, Salt Lake City
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-11 · NCT07577765The Acute T-Rex (Timing of Resistance Exercise) Study
- University of Utah HPER E Buildling, Salt Lake City
Renkami dalyviai
Amžius nuo 50 iki 74 · Visoms lytims · Atnaujinta 2025-04-03 · NCT06366399Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.